MYGN - Myriad Genetics, Inc. News

GainersToday.com, Tracking Stock Market Picks

Enter Symbol:


Myriad Genetics, Inc. (MYGN)

Myriad Genetics, Inc. uses gene-based medicine to develop therapeutic and molecular diagnostic products. They employ a variety of proprietary proteomic technologies to discover disease genes and

to understand the role these genes and their related proteins play in the onset and progression of disease. They have integrated these technologies using bioinformatics and robotics systems to conduct their research efforts on a high-throughput basis. This has enabled them to identify numerous proteins as targets for new drugs and molecular diagnostic tests.

( Total: 22 Current Stock Recommendations )

Myriad Genetics, Inc. (22)

Sell

Hold 36%

Buy 55%

Filter by Gains: Show:

Rating:
Sell MYGN

8.07 %

Myriad Genetics, Inc. (MYGN) rated Sell with price target $15 by Gleacher & Company
Wednesday, Jun 16, 2010 10:25 AM ET

Rating:
Buy MYGN

19.95 %

Myriad Genetics, Inc. (MYGN) upgraded to Buy with price target $23 by Auriga U.S.A
Thursday, May 13, 2010 9:25 AM ET

Rating:
Buy MYGN

30.87 %

Myriad Genetics, Inc. (MYGN) rated Overweight with price target $30 by JP Morgan
Monday, Apr 26, 2010 10:25 AM ET

Rating:
Hold MYGN

Myriad Genetics, Inc. (MYGN) rated Market Perform with price target $29 by Mehta Partners
Monday, Mar 29, 2010 12:25 PM ET

Rating:
Sell MYGN

19.95 %

Myriad Genetics, Inc. (MYGN) rated Sell with price target $19 by Auriga U.S.A
Friday, Mar 5, 2010 8:25 AM ET

Rating:
Hold MYGN

Myriad Genetics, Inc. (MYGN) rated Hold with price target $24 by Jefferies & Co
Thursday, Jan 21, 2010 8:25 AM ET

Rating:
Sell MYGN

47.70 %

Myriad Genetics, Inc. (MYGN) downgraded to Underperform by Oppenheimer
Tuesday, Jan 12, 2010 1:44 PM ET

Rating:
Hold MYGN

7.24 %

Myriad Genetics, Inc. (MYGN) upgraded to Hold by Morgan Joseph
Wednesday, Nov 11, 2009 8:25 AM ET

Rating:
Hold MYGN

Myriad Genetics, Inc. (MYGN) rated Hold with price target $30 by Benchmark
Wednesday, Aug 26, 2009 8:25 AM ET

Rating:
Buy MYGN

125.20 %

Myriad Genetics, Inc. (MYGN) upgraded to Buy by Canaccord Adams
Wednesday, Aug 26, 2009 8:25 AM ET

Rating:
Buy MYGN

41.28 %

Myriad Genetics, Inc. (MYGN) rated Outperform by William Blair
Tuesday, Aug 4, 2009 8:25 AM ET

Rating:
Buy MYGN

35.83 %

Myriad Genetics, Inc. (MYGN) rated Buy with price target $35 by Soleil
Friday, Jul 17, 2009 8:25 AM ET

Rating:
Hold MYGN

69.23 %

Myriad Genetics, Inc. (MYGN) downgraded to Hold with price target $25 by Benchmark
Wednesday, Jul 1, 2009 8:25 AM ET

Rating:
Hold MYGN

59.53 %

Myriad Genetics, Inc. (MYGN) downgraded to Sector Perform by RBC Capital Mkts
Wednesday, Jul 1, 2009 8:25 AM ET

Rating:
Buy MYGN

38.21 %

Myriad Genetics, Inc. (MYGN) rated Overweight with price target $42 by Piper Jaffray
Wednesday, Jul 1, 2009 8:25 AM ET

Subscribe to GainersToday.com Newsletter.

GainersToday Picks Gadget

Add this gadget to your webpage

Accuracy Ranking 2010
Research Companies

Rank	Member	YTD Accuracy
1	WBB Securities	71.43 %
2	Broadpoint AmTech Research	59.09 %
3	Wells Fargo	53.16 %
4	Broadpoint AmTech	51.72 %
5	Brigantine	50.00 %
6	Feltl & Co.	48.53 %
7	Merriman	48.15 %
8	Standpoint Research	47.71 %
9	Next Generation	47.62 %
10	Davenport	47.10 %

» View more

Top 2010 Stock Market Picks Ranking

Rank	Member	Symbol	1 Week Gains
1	Ferris Baker Watts	SAR	932.76 %
2	Stifel Nicolaus	SAR	932.76 %
3	MDB Capital Group	KOOLD	332.69 %
4	RBC Capital Mkts	IBCP	90.95 %
5	Needham	INVX	83.33 %
6	Northland Securities	ADAM	72.23 %
7	Roth Capital	ADAM	72.23 %
8	Caris & Company	MGT	57.89 %
9	Sterne Agee	FSNM	53.84 %
10	Canaccord Adams	SLRY	41.17 %

» View more

Your Recent Stocks

Symbol	Last	Change
MYGN	16.10	0.62 %